Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference6 articles.
1. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA et al (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36: 71–93.
2. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K (2008). The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51: 2187–2196.
3. Cohen D (2006). Diabetes mellitus in schizophrenia or schizoaffective disorder: an iatrogenic or endogenic problem? (thesis), Haarlem, Netherlands. ISBN: 90-808509-3-4.
4. De Hert M, Detraux J, van Winkel R, Correll C (2011). Antipsychotic medications: metabolic, cardiovascular and cardiac risks. Nature Rev Endocr (in press).
5. Nielsen J, Skadhede S, Correll CU (2010). Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients. Neuropsychopharmacology 35: 1997–2004.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献